Vitiligo Complicating Diphencyprone Sensitization Therapy for Alopecia Universalis

The document discussed a case where vitiligo developed as a complication during diphencyprone sensitization therapy for treating alopecia universalis. The therapy, which aimed to stimulate hair growth in patients with complete hair loss, led to the unintended side effect of vitiligo, a condition characterized by the loss of skin pigmentation. This highlighted a potential risk associated with the treatment, suggesting that while diphencyprone could be effective for hair regrowth, it might also trigger other autoimmune responses.